secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0000950170-23-001791
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Labs amends warrants to allow cashless exercise at $1.00 per share for 10 days
--------------------------------------------------------------------------------

- Exercise price temporarily reduced from $4.25 to $1.00 for Feb 3-16, 2023.
- Maximum of 1,669,971 shares can be issued under Bridge Warrants during the limited period.
- Holders may elect cashless exercise receiving one-third of shares otherwise issuable.
- Anti-dilution adjustment provisions removed except for stock splits/dividends.
- The amendment also waives restrictions on issuing securities under the SPA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023001791/0000950170-23-001791-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023001791/hscs-20230203.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-001791

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer